title: How to Manage the Side Effects of New Targets Agents for Metastatic Colorectal Cancer.
authors.forename: Elisa
authors.initials: E
authors.lastname: Becze
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology / Q000451:nursing*; D006801:Humans; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009859:Oncology Nursing / Q000379:methods; D010671:Phenylurea Compounds / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000009:adverse effects*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects*
chemical_list: D020533:Angiogenesis Inhibitors; D010671:Phenylurea Compounds; D011725:Pyridines; D011993:Recombinant Fusion Proteins; C533178:aflibercept; C559147:regorafenib; D040262:Receptors, Vascular Endothelial Growth Factor